ÖZET
Amaç:
Telle işaretleme (WGL) non-palpabl meme lezyonlarının (NPBLs) cerrahi öncesi yerinin belirlenmesinde yaygın olarak kullanılan bir yöntemdir. Son zamanlarda geliştirilen bir teknik olan radyonüklid okült lezyon lokalizasyonu (ROLL) telle işaretlemeye önemli bir alternatiftir. Çalışmadaki amacımız bu iki yöntemi karşılaştırmak ve kliniğimizde son zamanlarda uygulanmaya başlanan ROLL yöntemi ile ilgili deneyimlerimizi paylaşmaktır.
Yöntemler:
NPBLs olup 2014-2017 yıllarında kliniğimizde cerrahi öncesi işaretleme yapılan hastaların raporları retrospektif olarak tarandı. Hastaların medikal kayıtları kontrol edilip, patolojik ve radyolojik bulguları, doğru lezyon lokalizasyonu, spesmen boyutu, operasyon süresi, cerrahi sinir pozitifliği, simultane sentinel lenf nodu biyopsi sayısı, komplikasyon oranları, hospitalizasyon süreleri karsılaştırıldı.
Results:
NPBLs olan 67 kadın (ortalama yaş, 52,7; yaş aralığı, 32-69 ) calışmaya alındı. ROLL uygulanan 25 hasta ve WGL uygulanan 42 hasta saptandı. Bu iki metodun da doğru lezyon lokalize etme oranları benzer yükseklikte bulundu (ROLL, 96%; WGL, 98%). ROLL tekniğinde operasyon süresi WGL grubuna göre daha uzun sürdü (p=0,001) ve sentinel lenf nod biyopsi sayısının ROLL grubunda daha fazla olduğu bulundu. Patolojik ve radyolojik bulgular, spesmen boyutu, cerrahi sinir pozitifliği, komplikasyon oranları, hospitalizasyon süreleri larşılaştırıldığında anlamlı fark bulunmadı.
Sonuç:
Non-palpabl meme lezyonlarında, ROLL ile işaretleme yöntemi oğrenme aşamasında dahi verdiği sonuçlarla telle işaretleme yöntemine alternatif olabilecek umut vaadeden bir yöntemdir. ROLL ile operasyon süresi klinisyenlerin alışması ile giderek kısalacaktır.
References
1
Markopoulos C, Kakisis J, Kouskos S, Kontzoglou K, Koufopoulos K, Gogas J. Management of nonpalpable, mammographically detectable breast lesions. World J Surg 1999; 23: 434-8.
2
Altomare V, Guerriero G, Giacomelli L, Battista C, Carino R, Montesano M, et al. Management of nonpalpable breast lesions in a modern functional breast unit. Breast Cancer Res Treat 2005; 93: 85-9.
3
Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131: 301-8.
4
Wilson M, Boggis CR, Mansel RE, Harland RN. Non-invasive ultrasound localization of impalpable breast lesions. Clin Radiol 1993; 47: 337-8.
5
Ahmed M, Rubio IT, Klaase JM, Douek M. Surgical treatment of nonpalpable primary invasive and in situ breast cancer. Nat Rev Clin Oncol 2015; 12: 645-63.
6
Marinovich ML, Azizi L, Macaskill P, Irwig L, Morrow M, Solin LJ, et al. The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 2016; 23: 3811-21.
7
Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 2005; 14: 1008-11.
8
Perdue P, Page D, Nellestein M, Salem C, Galbo C, Ghosh B. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions. Surgery 1992; 111: 656-9.
9
Harvey JA, Nicholson BT, Cohen MA. Finding early invasive breast cancers: a practical approach. Radiology 2008; 248: 61-76.
10
Frank HA, Hall FM, Steer ML. Preoperative localization of nonpalpable breast lesions demonstrated by mammography. N Engl J Med 1976; 295: 259-60.
11
Homer MJ, Smith TJ, Safaii H. Prebiopsy needle localization. Methods, problems, and expected results. Radiol Clin North Am 1992; 30: 139-53.
12
Rappaport W, Thompson S, Wong R, Leong S, Villar H. Complications associated with needle localization biopsy of the breast. Surg Gynecol Obstet 1991; 172: 303-6.
13
Mariscal Martinez A, Solà M, de Tudela AP, Julián JF, Fraile M, Vizcaya S, et al. Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. AJR Am J Roentgenol 2009; 193: 1001-9.
14
Bernardi S, Bertozzi S, Londero AP, Gentile G, Giacomuzzi F, Carbone A. Incidence and risk factors of the intraoperative localization failure of nonpalpable breast lesions by radio-guided occult lesion localization: a retrospective analysis of 579 cases. World J Surg 2012; 36: 1915-21.
15
Luini A, Zurrida S, Paganelli G, Galimberti V, Sacchini V, Monti S, et al. Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg 1999; 86: 522-25.
16
van Rijk MC, Tanis PJ, Nieweg OE, Loo CE, Olmos RV, Oldenburg HAS, et al. Sentinel node biopsy and concomitant probe-guided tumor excision of nonpalpable breast cancer. Ann Surg Oncol 2007; 14: 627-32.
17
Medina-Franco H, Abarca-Pérez L, Garcia-Alvarez MN, Ulloa-Gómez JL, Romero-Trejo C, Sepúlveda-Méndez J. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation. J Surg Oncol 2008; 97: 108-11.
18
Moreno M, Wiltgen JE, Bodanese B, Schmitt RL, Gutfilen B, da Fonseca LMB. Radioguided breast surgery for occult lesion localization-correlation between two methods. J Exp Clin Cancer Res 2008; 27: 29.
19
Ocal K, Dag A, Turkmenoglu O, Gunay EC, Yucel E, Duce MN. Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial. Clinics (Sao Paulo) 2011; 66: 1003-7.
20
Duarte C, Bastidas F, de los Reyes A, Martínez MC, Hurtado G, Gómez MC, et al. Randomized controlled clinical trial comparing radioguided occult lesion localization with wire-guided lesion localization to evaluate their efficacy and accuracy in the localization of nonpalpable breast lesions. Surgery 2016; 159: 1140-5.
21
Alamdaran SA, Farokh D, Haddad AS, Daghighi N, Modoodi E, Sadeghi R, et al. Assessment of Ultrasound/Radio-guided Occult Lesion Localization in Non-palpable Breast Lesions. Asia Ocean J Nucl Med Biol 2018; 6: 10-4.
22
Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators. Cancer 1998; 82: 679-88.
23
Schwartz GF, Feig SA, Patchefsky AS. Significance and staging of nonpalpable carcinomas of the breast. Surg Gynecol Obstet 1988; 166: 6-10.
24
Skinner MA, Swain M, Simmons R, McCarty KS Jr, Sullivan DC, Iglehart JD. Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. Ann Surg 1988; 208: 203-8.
25
Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology 2006; 239: 385-91.
26
Feggi L, Basaglia E, Careione S, Querzoli P, Soliani G, Ascanelli S, et al. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation. Eur J Nucl Med 2001; 28: 1589-96.
27
Sajid MS, Parampalli U, Haider Z, Bonomi R. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis. J Surg Oncol 2012; 105: 852-58.
28
Tartter PI, Bleiweiss IJ, Levchenko S. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg 1997; 185: 268-73.
29
Nadeem R, Chagla LS, Harris O, Desmond S, Thind R, Titterrell C, et al. Occult breast lesions: a comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL). Breast 2005; 14: 283-89.
30
Van Esser S, Hobbelink M, Van der Ploeg IM, Mali WP, Van Diest PJ, Borel Rinkes IH, et al. Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer. J Surg Oncol 2008; 98: 526-29.
31
Machado RH, Oliveria AC, Rocha AC, Landesmann MC, Martins FP, Lopes SA, et al. Radioguided occult lesion localization (ROLL) and excision of breast lesions using technetium-99m-macroaggregate albumin and air injection control. J Exp Clin Cancer Res 2007; 26: 323-7.
32
Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg 2004; 91: 1575-7.
33
Sarlos D, Frey LD, Haueisen H, Landmann G, Kots LA, Schaer G. Radioguided occult lesion localization (ROLL) for treatment and diagnosis of malignant and premalignant breast lesions combined with sentinel node biopsy: a prospective clinical trial with 100 patients. Eur J Surg Oncol 2009; 35: 403-8.
34
Zurrida S, Galimberti V, Monti S, Luini A. Radioguided localization of occult breast lesions. Breast 1998; 7: 11-3.
